Concert Pharmaceuticals, Inc. announced that it has appointed James V. Cassella, Ph.D. as Chief Development Officer. In this newly created role, Dr. Cassella will lead Concert's product development strategy and operations and will have responsibility for all preclinical, clinical and manufacturing activities. Dr. Cassella brings to Concert more than 25 years of experience in drug development, including experience with product development, clinical trial design and execution, regulatory affairs, and product registration in the US and EU.

Most recently, Dr. Cassella served as Executive Vice President, Research and Development and Chief Scientific Officer of Alexza Pharmaceuticals, Inc.